A Day Up For Aridis Pharmaceuticals, Inc.

Wed, Jan 25, 2023 at 06:59 PM
A Day Up For Aridis Pharmaceuticals, Inc.

Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) soared at $1.23, representing a gain of 46.4%. On Wed, Jan 25, 2023, ARDS:NASDAQ hit a New 2-Week Intraday High of $1.34. The stock appeared on our News Catalysts scanner on Wed, Jan 25, 2023 at 04:33 PM in the 'BIOTECH' category. From Wed, Jan 11, 2023, the stock recorded 44.44% Up Days and 10.00% Green Days

About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.